XML 66 R53.htm IDEA: XBRL DOCUMENT v3.19.1
Share-based payments (Tables)
12 Months Ended
Dec. 31, 2018
Share-based payments  
Schedule of movement in number of shares under share purchase payment plans

 

 

 

 

 

    

Number of Series A

 

 

    

shares 

 

Outstanding as of December 31, 2015

 

617,001

 

Purchased during the year

 

513,002

 

Granted during the year

 

 —

 

Exercised/vested during the year

 

(425,536)

 

Forfeited during the year

 

(86,419)

 

Outstanding as of December 31, 2016

 

618,048

*

Purchased during the year

 

547,310

 

Granted during the year

 

 —

 

Exercised/vested during the year

 

(345,270)

 

Forfeited during the year

 

 —

 

Outstanding as of December 31, 2017

 

820,088

*

Purchased during the year

 

3,208,115

 

Granted during the year

 

 —

 

Exercised/vested during the year

 

(353,457)

 

Forfeited during the year

 

(121,451)

 

Outstanding as of December 31, 2018

 

3,553,295

*


*These shares are presented as treasury shares in the consolidated statement of financial position as of December 31, 2018, 2017 and 2016.

Schedule of weighted average assumptions used to estimate the fair market value of the MIP at the date of grant

 

 

 

 

 

    

2012

 

Dividend yield (%)

 

0.00

%

Volatility (%)

 

37.00

%

Risk–free interest rate (%)

 

5.96

%

Expected life of share options (years)

 

8.8

 

Exercise share price (in Mexican pesos Ps.)

 

5.31

 

Exercise multiple

 

1.1

 

Fair value of the stock at grant date

 

1.73

 

 

Schedule of movement in number of shares options and fixed exercise prices

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

Total in

 

 

Number of share

 

Exercise price

 

thousands of

 

    

options 

    

in Mexican pesos 

    

Mexican pesos 

Outstanding as of December 31, 2015

 

15,857,856

 

Ps.

5.31

 

Ps.

84,269

Granted during the year

 

 —

 

 

 —

 

 

 —

Forfeited during the year

 

 —

 

 

 —

 

 

 —

Exercised during the year

 

(3,299,999)

 

 

5.31

 

 

(17,536)

Outstanding as of December 31, 2016

 

12,557,857

 

Ps.

5.31

 

Ps.

66,733

Granted during the year

 

 —

 

 

 —

 

 

 —

Forfeited during the year

 

 —

 

 

 —

 

 

 —

Exercised during the year

 

(120,000)

 

 

5.31

 

 

(638)

Outstanding as of December 31, 2017

 

12,437,857

 

Ps.

5.31

 

Ps.

66,095

Granted during the year

 

 —

 

 

 —

 

 

 —

Forfeited during the year

 

 —

 

 

 —

 

 

 —

Exercised during the year

 

(2,003,876)

 

 

5.31

 

 

(10,654)

Outstanding as of December 31, 2018

 

10,433,981

 

Ps.

5.31

 

Ps.

55,441

 

Schedule of retention plan expenses recognized

 

 

 

 

 

 

 

 

 

 

 

    

2018

    

2017

    

2016

(Benefit) expense arising from cash-settled share-based payments transactions

 

Ps.

(5,238)

 

Ps.

(25,498)

 

Ps.

86,100

Expense arising from equity-settled share-based payments transactions

 

 

19,980

 

 

13,508

 

 

7,816

Total expense (benefit) arising from share-based payments transactions

 

Ps.

14,742

 

Ps.

(11,990)

 

Ps.

93,916

 

Share purchase plan  
Share-based payments  
Schedule of vesting period of shares granted

 

 

 

Number of Series A

    

 

shares 

    

Vesting period 

1,284,373

 

November 2018 - 2019

1,207,862

 

November 2019 - 2020

1,061,060

 

November 2020 - 2021

3,553,295

 

  

 

SARs - cash settled  
Share-based payments  
Schedule of vesting period of shares granted

 

 

 

Number of SARs 

    

Exercisable date 

1,348,777

 

November 2019

757,809

 

November 2020

2,106,586

*

  

 

MIP II  
Share-based payments  
Schedule of vesting period of shares granted

 

 

 

Number of SARs 

    

Vesting date

1,695,500

 

February 2019

2,825,840

 

February  2020

3,391,020

 

February  2021

7,912,360

*  

  


* Includes forfeited SARs of 1,563,520,  0, and 0, for the years ended December 31, 2018, 2017 and 2016, respectively.